Table 3.
Research domains of the 100 most cited papers in SBRT until 2021.
| Research domains a | Number of papers | Total citations | Average citations per year (per paper) | Publication year |
|---|---|---|---|---|
| Primary carcinoma | 54 | 15475 | 31.94 | 2002-2019 |
| Lung cancer | 33 | 10683 | 36.77 | 2002-2019 |
| Prostate carcinoma | 7 | 1445 | 21.90 | 2009-2013 |
| Liver carcinoma | 9 | 2383 | 27.74 | 2006-2016 |
| Pancreatic carcinoma | 5 | 964 | 21.71 | 2008-2015 |
| Metastatic carcinoma | 38 | 8562 | 30.80 | 2002-2020 |
| Spinal metastasis | 8 | 1415 | 17.27 | 2009-2013 |
| Oligometastasesb | 30 | 7147 | 34.40 | 2002-2020 |
| Radiobiology | 2 | 600 | 25.66 | 2012-2014 |
| Radiophysics | 3 | 527 | 11.11 | 2000-2009 |
| Clinical practice of SBRT | 8 | 2395 | 27.43 | 2004-2016 |
| SBRT + immunotherapy | 4 | 786 | 63.32 | 2016-2019 |
a
Some papers belonged to two domains.
b
The studies about oligometastases included metastases in multiple sites.